VS-041

N/A

Report date: 2025/10/24 20:00:54
NME

Base Information

Drug NameVS-041
Drug Alias NameVS-041
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMatrix metalloproteinase inhibitors
TargetsMatrix metalloproteinase
Therapy Area/IndicationsHeart Failure, DiastolicHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesVasa Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesVasa Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsHeart Failure, Diastolic
Inactive IndicationsHeart Failure

Other Information

ATC CodeN/A
Related LinksN/A